Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nalmefene”

35 trials

Showing 20 of 35 results

Testing effectiveness (Phase 2)Study completedNCT03034408
What this trial is testing

Nalmefene, Baclofen and Impulsivity in Subjects With Alcohol Use Disorder and Healthy Control Subjects

Who this might be right for
Alcohol Use Disorder
Prof. Daniele Zullino 37
Large-scale testing (Phase 3)Study completedNCT00132119
What this trial is testing

Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling

Who this might be right for
Pathological Gambling
Somaxon Pharmaceuticals 233
Not applicableStudy completedNCT02492581
What this trial is testing

Use of Selincro and Impact on Usual Practice

Who this might be right for
Alcohol Dependence
University of Bordeaux 700
Large-scale testing (Phase 3)Study completedNCT00812461
What this trial is testing

Efficacy of Nalmefene in Patients With Alcohol Dependence

Who this might be right for
Alcohol Dependence
H. Lundbeck A/S 678
Large-scale testing (Phase 3)WithdrawnNCT02824354
What this trial is testing

Nalmefene in Patients With Alcoholic Compensated Cirrhosis for the Treatment of Alcohol Dependence.

Who this might be right for
CirrhosisAlcohol DependenceNalmefene
Centre Hospitalier Universitaire, Amiens
Large-scale testing (Phase 3)Study completedNCT00811720
What this trial is testing

Efficacy of Nalmefene in Patients With Alcohol Dependence

Who this might be right for
Alcohol Dependence
H. Lundbeck A/S 598
Not applicableStudy completedNCT03096730
What this trial is testing

Effect of Dexmedetomidine Combined With Low-dose Nalmefene on Preventing Remifentanil-induced Postoperative Hyperalgesia

Who this might be right for
PainAnesthesia
Tianjin Medical University General Hospital 150
Early research (Phase 1)Study completedNCT03279562
What this trial is testing

Patient Driven Recovery With Nalmefene and Coaching

Who this might be right for
Opioid-use DisorderHarmful; Use, Alcohol
Yale University 10
Post-approval studies (Phase 4)Study completedNCT04713358
What this trial is testing

Effect of Nalmefene on the Quality of Resuscitation in Patients Under General Anesthesia

Who this might be right for
Resuscitation
RenJi Hospital 542
Large-scale testing (Phase 3)Study completedNCT00811941
What this trial is testing

Safety and Efficacy of Nalmefene in Patients With Alcohol Dependence

Who this might be right for
Alcohol Dependence
H. Lundbeck A/S 665
Early research (Phase 1)Study completedNCT02679469
What this trial is testing

A Single-center, Open-label, Single-dose Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Nalmefene 10 mg Tablets in Healthy Japanese Male Subjects

Who this might be right for
Alcohol Dependence
Otsuka Pharmaceutical Co., Ltd. 7
Large-scale testing (Phase 3)Looking for participantsNCT05540288
What this trial is testing

NAlmefene Versus Placebo in Addition to Treatment as Usual on Craving in Behavioural Addictions

Who this might be right for
Behavioural Addiction
Nantes University Hospital 266
Early research (Phase 1)Study completedNCT01969617
What this trial is testing

Effects of Nalmefene After Single Dose on the Blood Oxygen Level Dependent (BOLD) fMRI Signal in the Ventral Striatum to Reward Responding in the Monetary Incentive Delay Task (MIDT), in Non-treatment Seeking Subjects With Alcohol Dependence Following Alcohol Challenge

Who this might be right for
Alcohol Dependence
H. Lundbeck A/S 22
Large-scale testing (Phase 3)WithdrawnNCT06408714
What this trial is testing

Nalmefene vs Naloxone for the Treatment of Recurrent Respiratory Depression After Opioid Overdose

Who this might be right for
Opioid OverdoseOpiate Overdose
University of New Mexico
Testing effectiveness (Phase 2)UnknownNCT02934919
What this trial is testing

Evaluation of Nalmefene in Impulse Control Disorders in Parkinson's Disease: A Prospective Open Label Study

Who this might be right for
Impulse Control DisordersParkinson Disease
University Hospital, Clermont-Ferrand 30
Post-approval studies (Phase 4)Study completedNCT00000437
What this trial is testing

Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)

Who this might be right for
AlcoholismSmoking
The Scripps Research Institute 60
Post-approval studies (Phase 4)WithdrawnNCT05808881
What this trial is testing

Clinical Outcomes From Nalmefene

Who this might be right for
Opioid Overdose
Purdue Pharma LP
Very early researchEnded earlyNCT02372318
What this trial is testing

Single-dose of Nalmefene to Modulate Neural Alcohol Cue Reactivity

Who this might be right for
Alcoholism
Central Institute of Mental Health, Mannheim 23
Post-approval studies (Phase 4)Ended earlyNCT02195817
What this trial is testing

Study of 18 mg Selincro® As-needed Use, in the Treatment of Patients With Alcohol Dependence in Primary Care

Who this might be right for
Alcohol Dependence
H. Lundbeck A/S 378
Large-scale testing (Phase 3)Study completedNCT02364947
What this trial is testing

A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial)

Who this might be right for
Alcohol Dependence
Otsuka Pharmaceutical Co., Ltd. 678
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation